R&D

Cofactor Genomics invested $3.8 million in its St. Louis expansion, plans to create 24 new jobs

Gov. Jay Nixon today joined officials from Cofactor Genomics to celebrate the opening of the company’s new $3.8 million headquarters and laboratory facility in St. Louis. As part of this expansion, ... Read More

Schnucks moves into health care

Schnucks, the Midwest and St. Louis chain, opened its first Schnucks Infusion Solutions facility on Page Service Road in September to treat acute and chronic conditions. Infusion therapy involves injecting medicine ... Read More

Pharmaceutical research company plans to create 320 jobs at facility in St. Charles

Pharma Medica Research, Inc., a contract research organization serving the pharmaceutical and biotechnology industry, plans to make a $30.8 million capital investment and create 320 jobs at its first U.S. facility ... Read More

Monsanto’s Billion-Dollar Bet Brings Big Data to the Farm

Monsanto (MON) has agreed to acquire the Climate Corp. for $930 million. The real stunner of a deal marks one of the largest buys of a new-era data analytics company. Climate ... Read More

MOgene gets $1.5 million grant to make bacteria for fuel

A St. Louis startup has received $1.5 million from the Department of Energy to engineer a bacteria that can convert methane into a liquid fuel. MOgene Green Chemicals LLC, a subsidiary ... Read More

$4.6M grant to finance incubator, Danforth greenhouse

The U.S. Department of Commerce awarded St. Louis County Economic Council and Donald Danforth Plant Science Center a $4.6 million grant to expand plant and life sciences in St. Louis County. ... Read More

Barnes-Jewish 1 of 14 hospitals on U.S. News Honor Roll

Barnes-Jewish Hospital and its physician partners at Washington University School of Medicine are one of 14 hospitals and medical institutions nationwide included on U.S. News & World Report’s list of “America’s ... Read More

Monsanto, BASF add wheat, $1B to crop venture

BASF and Monsanto Co. said Wednesday that they are expanding their joint efforts to develop higher-yielding and stress-tolerant crops to include wheat and may add more than $1 billion to those ... Read More

Hospira’s generic antibiotic gets FDA green light

Hospira Inc. said Tuesday the Food and Drug Administration has approved its generic version of AstraZeneca’s antibiotic Merrem. The FDA cleared Hospira’s version of intravenous meropenem in 500-milligram and 1-gram vials. ... Read More

Kansas City forum connects animal health firms with investors

Area animal health companies seeking venture capital have an coming opportunity close to home. The KC Animal Health Corridor is holding its second KC Animal Health Investment Forum on Aug. 31 ... Read More